https://www.mediware.com () —
Mediware Information Systems, Inc. (NASDAQ: MEDW), a specialist
provider of information systems focused on complex clinical solutions
for Blood Management, Medication Management and Performance
Management, today announced that it is renewing its relationship with
its long standing financial advisor, William Blair & Company.
As part of the ongoing agreement, Mediware management will be working
with William Blair to explore a variety of strategic alternatives to
enhance shareholder value. The company routinely performs internal
strategic assessments and has not set a definitive timetable for
completion of the evaluation. There can be no assurance that the
evaluation will lead to any change in operating plans for the company
or result in the pursuit of any specific alternative.
As in the past, the company intends to disclose developments regarding
this process only if and when material.
About Mediware Mediware delivers interoperable best-of-breed software
systems that integrate with electronic medical records to improve
efficiencies and address safety concerns enabling healthcare
organizations to improve care processes while decreasing costs. Core
Mediware solutions include blood management technologies for hospitals
and blood centers; medication management solutions for hospitals,
behavioral health facilities, infusion and specialty pharmacy
providers; and business intelligence-based performance management
solutions for clinical, regulatory and financial aspects of the
broader healthcare market. For more information about Mediware
products and services, visit our Web site at www.mediware.com
(https://www.mediware.com) .
Certain statements in this press release may constitute
“forward-looking” statements within the meaning of the Private
Securities Litigation Reform Act of 1995, as the same may be amended
from time to time (the “Act”) and in releases made by the SEC from
time to time. Such forward-looking statements are not based on
historical facts and involve known and unknown risks, uncertainties
and other factors disclosed in the Company’s Annual Report on Form
10-K for the year ended June 30, 2009, and in subsequent Quarterly
Reports on Form 10-Q, which may cause the actual results of the
Company to be materially different from any future results expressed
or implied by such forward-looking statements. The Company disclaims
any obligation to update its forward-looking statements.